ImageneBio (IMA) Total Non-Current Liabilities (2023 - 2025)

ImageneBio has disclosed Total Non-Current Liabilities across 3 years of filings, most recently posting $19.0 million for Q4 2025.

• Total Non-Current Liabilities for Q4 2025 came in at $19.0 million, up 8.71% year-over-year; the trailing twelve-month figure through Dec 2025 was $19.0 million (up 8.71% YoY), and the FY2025 annual result was $19.0 million, up 8.71% from the prior year.
• Total Non-Current Liabilities came in at $19.0 million for Q4 2025 at ImageneBio, down from $19.9 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $21.4 million in Q4 2023 to a low of $9.2 million in Q2 2025.
• The 3-year median for Total Non-Current Liabilities is $16.5 million (2024), against an average of $15.8 million.
• Peak annual rise in Total Non-Current Liabilities reached 45.42% in 2025, while the deepest fall reached 32.56% in 2025.
• ImageneBio's Total Non-Current Liabilities stood at $21.4 million in 2023, then decreased by 18.41% to $17.4 million in 2024, then gained by 8.71% to $19.0 million in 2025.
• The last three Total Non-Current Liabilities figures came in at $19.0 million (Q4 2025), $19.9 million (Q3 2025), and $9.2 million (Q2 2025), per Business Quant data.